BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

48 hedge funds and large institutions have $3.83M invested in Biotech Acquisition Company Warrant in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-3
Holders Change %
-5.88%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
4
Closed
4
Calls
$5.82M
Puts
Net Calls
+$5.82M
Net Calls Change
+$98K
Name Holding Trade Value Shares
Change
Shares
Change %
RCM
1
Radcliffe Capital Management
Pennsylvania
$2.05M
BFM
2
Boothbay Fund Management
New York
$611K -$33.7K -3,339 -5%
LP
3
LMR Partners
United Kingdom
$505K
SCM
4
Segantii Capital Management
Hong Kong
$252K
HIM
5
HGC Investment Management
Ontario, Canada
$78K
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$39.7K
AC
7
Aristeia Capital
Connecticut
$37.4K
RA
8
Ramius Advisors
New York
$36.4K +$98 +1,540 +0.3%
CCP
9
Corbin Capital Partners
New York
$29.7K
QGA
10
Q Global Advisors
Texas
$19K
ACM
11
Atalaya Capital Management
New York
$16.7K
LA
12
Linden Advisors
New York
$15.4K
SCM
13
Shaolin Capital Management
Florida
$13K
TI
14
Telemetry Investments
New York
$10K
SC
15
Sculptor Capital
New York
$9.32K
DKCM
16
Davidson Kempner Capital Management
New York
$9K
TCM
17
Tenor Capital Management
New York
$8.97K
MI
18
MMCAP International
Cayman Islands
$8.95K
AC
19
Antara Capital
New York
$7K
RCM
20
Rivernorth Capital Management
Florida
$6.65K
ACA
21
Arena Capital Advisors
California
$6.39K
PC
22
Periscope Capital
Ontario, Canada
$6.39K
CH
23
CVI Holdings
Delaware
$6.39K
Walleye Capital
24
Walleye Capital
New York
$4.14K
HF
25
HRT Financial
New York
$4K